The efficacy and safety of SGLT2 inhibitors combined with ACEI/ARBs in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis
Supplementary Material 1: The risk of bias of enrolled trails according to version 2 of the Cochrane risk-of-bias tool. (A): The graph of risk of bias; (B): The summary of risk of bias. Supplementary Material 2: Forest plot of sensitivity analysis by omitting Perkovic's study. Supplementary Material 3: Forest plots of subgroup analyses according to ages, baseline HbA1c, eGFR, or SBP/DBP levels of participants.